Trials / Completed
CompletedNCT00700687
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- POZEN · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PA32540 | aspirin/omeprazole |
| DRUG | PA32540 and celecoxib | aspirin/omeprazole and celecoxib |
| DRUG | aspirin and [NSAID] | aspirin and \[NSAID\] |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-06-19
- Last updated
- 2009-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00700687. Inclusion in this directory is not an endorsement.